The Journal of Clinical Endocrinology & Metabolism · 2010 · 58 citations · 15 references
MedicineEndocrinologyPharmacotherapyBone MetabolismEndocrine PharmacotherapyHuman NutritionBone Metabolism DisordersBone Metabolism PharmacotherapyLipid MetabolismThyroid Hormone BiochemistryBody Weight RegulationChronic Heart Failure ManagementDouble-blind TrialsThyroid Disorder PharmacotherapyThyroid Function TestsThyroid Hormone Effects On BoneThyroid Hormone Pharmacology
CONTEXT: Widespread thyroid hormone actions offer the possibility of developing selective thyromimetic analogs with salutary metabolic properties. Consequently, effects of diiodothyropropionic acid (DITPA) on body weight, serum lipoproteins, and bone metabolism markers were studied in a prospective, controlled, double-blind 24-wk trial, which was primarily designed to assess treatment of stable chronic heart failure. DESIGN: Eighty-six patients (aged 66 +/- 11 yr, mean +/- sd) were randomized (1:2) to placebo or an escalating DITPA dose (90 to 180, 270, and 360 mg/d) over 8 wk until serum TSH was less than 0.02 mU/liter. Patients were studied at 2, 4, 6, 8, 16, and 24 wk and after 4 wk off study drug. Only 21 DITPA-treated and 27 placebo patients completed the full 24 wk of therapy. RESULTS: DITPA therapy lowered serum TSH levels and, to a lesser extent, serum T(3) and T(4), but there were no differences in clinical manifestations of thyrotoxicosis or hypothyroidism. Serum total and low-density lipoprotein cholesterol levels both decreased on DITPA; there was a transient decrease in triglycerides and no change in high-density lipoprotein cholesterol. DITPA therapy was associated with significant reduction in body weight, 12.5 lb at 24 wk. Increases in serum osteocalcin, N-telopeptide, and deoxypyridinoline levels were consistent with increased bone turnover on DITPA. CONCLUSION: This investigation of DITPA actions demonstrated its efficacy in reducing body weight and lowering total and low-density lipoprotein cholesterol levels. However, DITPA's adverse effects at doses used resulted in a high dropout rate and potentially dangerous skeletal actions were observed.
15
The action of thyroid hormones at the cell level
JR Tata, Lars Ernster, Olle R. Lindberg et al. · Biochemical Journal · 1963 · 531 citations · Full text
Lisen Johansson, Mats Rudling, Thomas S. Scanlan et al. · Proceedings of the National Academy of Sciences · 2005 · 199 citations · Full text
Anders Berkenstam, Jens D. Kristensen, Karin Mellström et al. · Proceedings of the National Academy of Sciences · 2007 · 194 citations · Full text
STATISTICAL METHODS APPLIED TO THE DIAGNOSIS OF HYPOTHYROLDISM
W. Z. Billewicz, Robert S. Chapman, J. Crooks et al. · QJM · 1969 · 183 citations